Last reviewed · How we verify
NCT04630197
Using Online Delivered Therapy and Brain Imaging to Better Understand OCD
NA trial testing e-CBT in Obsessive-Compulsive Disorder in 10 participants. Completed in 28 July 2022.
1 June 2022
Quick facts
| Lead sponsor | Callum Stephenson |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 January 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 28 July 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- e-CBT
Conditions studied
- Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →
Sponsor
Callum Stephenson
Who can join
Adults 18 to 65, any sex, with Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will implement an e-CBT program for OCD and observe its effects on brain activation levels using functional magnetic resonance imaging (fMRI). It is hypothesized that brain activation levels in the basal ganglia and frontal cortex will decrease following treatment. Individuals with OCD will be offered a 16-week e-CBT program with ERP mirroring in-person CBT content that will be administered through a secure online platform. Efficacy of treatment will be evaluated using clinically validated symptomology questionnaires at baseline, week 8, week 16, and at a 6-month follow-up. Using fMRI at baseline and post-treatment, brain activation levels will be assessed at resting state, and while exposed to anxiety-inducing images (i.e., dirty dishes if cleanliness is an obsession). The effects of treatment on brain activation levels and the correlation between symptom changes and activation levels will be analyzed.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Using electronically delivered therapy and brain imaging to understand OCD pathology: A pilot feasibility study.
Stephenson C, Malakouti N, Nashed JY, Salomons T, et al · · 2023 · cited 3× · PMID 36970278 · DOI 10.3389/fpsyt.2023.1050530 -
Using Electronically Delivered Therapy and Brain Imaging to Understand Obsessive-Compulsive Disorder Pathophysiology: Protocol for a Pilot Study.
Stephenson C, Malakouti N, Nashed JY, Salomons T, et al · · 2021 · cited 3× · PMID 34348889 · DOI 10.2196/30726
Verify or expand the search:
- PubMed search for NCT04630197
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of e-CBT
Trials testing the same drug.
- NCT06865066 — Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety · NA · recruiting
- NCT05648175 — Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression · NA · recruiting
- NCT04747873 — Incorporating Stepped Care Approach Into e-CBT for Depression · NA · completed
- NCT04754438 — Comparing the Efficacy of E-CBT to Mental Health Coaching for GAD · NA · completed
- NCT04478058 — Feasibility and Effectiveness of Delivering CBT Through OPTT for Depression · NA · completed
Other recruiting trials for Obsessive-Compulsive Disorder
Currently open trials in the same condition.
- NCT06575075 — Pilot Study of RR-HNK in OCD · Phase 1, PHASE2 · recruiting
- NCT05783817 — MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) · Phase 2 · recruiting
- NCT07065669 — Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation · NA · recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
- NCT07000812 — EEG Evaluation of CBT for Obsessive-Compulsive Disorder · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04630197 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Callum Stephenson
- Last refreshed: 27 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04630197.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing